Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Operating Expenses: 2013-2024

Historic Operating Expenses for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to $187.7 million.

  • Soleno Therapeutics' Operating Expenses rose 183.62% to $5.2 million in Q4 2017 from the same period last year, while for Dec 2017 it was $12.2 million, marking a year-over-year increase of 18.21%. This contributed to the annual value of $187.7 million for FY2024, which is 353.49% up from last year.
  • As of FY2024, Soleno Therapeutics' Operating Expenses stood at $187.7 million, which was up 353.49% from $41.4 million recorded in FY2023.
  • Over the past 5 years, Soleno Therapeutics' Operating Expenses peaked at $187.7 million during FY2024, and registered a low of $24.4 million during FY2022.
  • For the 3-year period, Soleno Therapeutics' Operating Expenses averaged around $84.5 million, with its median value being $41.4 million (2023).
  • Data for Soleno Therapeutics' Operating Expenses shows a peak YoY surged of 353.49% (in 2024) over the last 5 years.
  • Yearly analysis of 3 years shows Soleno Therapeutics' Operating Expenses stood at $24.4 million in 2022, then soared by 69.63% to $41.4 million in 2023, then skyrocketed by 353.49% to $187.7 million in 2024.